Article Details

Pfizer set to swallow Canadian cancer drug developer Trillium Therapeutics in US$2.26-billion deal

Retrieved on: 2021-08-23 11:28:24

Tags for this article:

Click the tags to see associated articles and topics

Pfizer set to swallow Canadian cancer drug developer Trillium Therapeutics in US$2.26-billion deal. View article details on hiswai:

Excerpt

It's the second largest deal for a Canadian biotech company on record, ... signals sent by tumors to shield against the immune system and send an additional ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up